Cargando…

Utility of the 4C ISARIC mortality score in hospitalized COVID-19 patients at a large tertiary Saudi Arabian center

BACKGROUND: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) 4C mortality score has been used before as a valuable tool for predicting mortality in COVID-19 patients. We aimed to address the utility of the 4C score in a well-defined Saudi population with COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Elhassan, Usama E., Alqahtani, Saad M.A., Al Saglan, Naif S., Hawan, Ali, Alqahtani, Faisal S., Almtheeb, Roaa S., Abdelwahab, Magda S.R., AlFlan, Mohammed A., Alfaifi, Abdulaziz S.Y., Alqahtani, Mohammed A., Alshafa, Fawwaz A., Alsalem, Ali A., Al-Imamah, Yahya A., Abdelwahab, Omar S.A., Attia, Mohammed F., Mahmoud, Ibrahim M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483479/
https://www.ncbi.nlm.nih.gov/pubmed/37692055
http://dx.doi.org/10.4081/mrm.2023.917
Descripción
Sumario:BACKGROUND: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) 4C mortality score has been used before as a valuable tool for predicting mortality in COVID-19 patients. We aimed to address the utility of the 4C score in a well-defined Saudi population with COVID-19 admitted to a large tertiary referral hospital in Saudi Arabia. METHODS: A retrospective study was conducted that included all adults COVID‑19 patients admitted to the Armed Forces Hospital Southern Region (AFHSR), between January 2021 and September 2022. The receiver operating characteristic (ROC) curve depicted the diagnostic performance of the 4C Score for mortality prediction. RESULTS: A total of 1,853 patients were enrolled. The ROC curve of the 4C score had an area under the curve of 0.73 (95% CI: 0.702-0.758), p<0.001. The sensitivity and specificity with scores >8 were 80% and 58%, respectively, the positive and negative predictive values were 28% and 93%, respectively. Three hundred and sixteen (17.1%), 638 (34.4%), 814 (43.9%), and 85 (4.6%) patients had low, intermediate, high, and very high values, respectively. There were significant differences between survivors and non-survivors with regard to all variables used in the calculation of the 4C score. Multivariable logistic regression analysis revealed that all components of the 4C score, except gender and O(2) saturation, were independent significant predictors of mortality. CONCLUSIONS: Our data support previous international and Saudi studies that the 4C mortality score is a reliable tool with good sensitivity and specificity in the mortality prediction of COVID-19 patients. All components of the 4C score, except gender and O(2) saturation, were independent significant predictors of mortality. Within the 4C score, odds ratios increased proportionately with an increase in the score value. Future multi-center prospective studies are warranted.